王国平, 汤清清, 林佩丽, 陈钰, 王雨银, 陈霞. 温岭地区20142018年幽门螺杆菌对克拉霉素和左氧氟沙星耐药趋势分析[J]. 上海预防医学, 2021, 33(4): 296-301. DOI: 10.19428/j.cnki.sjpm.2021.19840
引用本文: 王国平, 汤清清, 林佩丽, 陈钰, 王雨银, 陈霞. 温岭地区20142018年幽门螺杆菌对克拉霉素和左氧氟沙星耐药趋势分析[J]. 上海预防医学, 2021, 33(4): 296-301. DOI: 10.19428/j.cnki.sjpm.2021.19840
WANG Guo-ping, TANG Qing-qing, LIN Pei-li, CHEN Yu, WANG Yu-yin, CHEN Xia. Trend analysis of Helicobacter pylori resistance to clarithromycin and levofloxacin in Wenling area from 2014 to 2018[J]. Shanghai Journal of Preventive Medicine, 2021, 33(4): 296-301. DOI: 10.19428/j.cnki.sjpm.2021.19840
Citation: WANG Guo-ping, TANG Qing-qing, LIN Pei-li, CHEN Yu, WANG Yu-yin, CHEN Xia. Trend analysis of Helicobacter pylori resistance to clarithromycin and levofloxacin in Wenling area from 2014 to 2018[J]. Shanghai Journal of Preventive Medicine, 2021, 33(4): 296-301. DOI: 10.19428/j.cnki.sjpm.2021.19840

温岭地区20142018年幽门螺杆菌对克拉霉素和左氧氟沙星耐药趋势分析

Trend analysis of Helicobacter pylori resistance to clarithromycin and levofloxacin in Wenling area from 2014 to 2018

  • 摘要:
    目的了解温岭地区幽门螺杆菌(Helicobacter pylori,Hp)对克拉霉素和左氧氟沙星的耐药情况与变化趋势,指导该地区根除Hp临床用药。
    方法选择2014年1月至2018年12月因消化道症状在温岭市第一人民医院就诊患者为研究对象,共计66 515例。根据患者年龄段分为童年期(0~6岁);少年期(7~17岁);青年期(18~40岁);中年期(41~65岁);老年期(≥66岁)。所有患者均进行胃镜检查、胃黏膜活体组织检查及Hp分离培养,并对其进行克拉霉素和左氧氟沙星耐药性检测分析。
    结果2016、2017、2018年Hp阳性率呈明显下降趋势(χ2=14.317、47.079、88.054,均P<0.05)。2014—2018年Hp对克拉霉素平均耐药率为22.72%(4 732/20 831), 呈逐年上升趋势,但2017年后上升幅度较缓;Hp对左氧氟沙星平均耐药率为30.55%(6 364/20 831),总体趋势呈现为2015—2017年急剧上升(χ2=38.383、49.569,均P<0.05),2017年后明显下滑(χ2=18.841,P<0.05)。克拉霉素耐药率随年龄增长呈现先下降后上升趋势,老年期克拉霉素耐药率为32.52%(763/2 346),高于青年期的22.09%(1 086/4 916)和中年期的21.21%(2 854/13 458),差异均有统计学意义(χ2=991.071、144.968,均P<0.05)。各年龄段患者Hp对左氧氟沙星耐药率随年龄增长急剧上升,从少年期的12.73%(14/110)上升至老年期的43.31%(1 016/2 346),差异有统计学意义(χ2=228.867,P<0.05)。
    结论近年来,温岭地区Hp阳性率有下降趋势。Hp对克拉霉素和左氧氟沙星的耐药率虽然近期有上升缓慢或下降趋势,但仍处于较高水平。在Hp根除方案的选择上,应考虑到不同年龄段患者之间的差异,尤其是少年期患者的用药选择。

     

    Abstract:
    ObjectiveTo understand the trend of Helicobacter pylori (Hp) resistance to clarithromycin and levofloxacin and to provide guidance for Hp eradication therapy.
    MethodsFrom January 2014 to December 2018, a total of 66 515 patients with gastrointestinal symptoms were enrolled in the First People's Hospital of Wenling. The patients were divided into the following groups: childhood (0 to 6 years old); juvenile (7 to 17 years old); youth (18 to 40 years old),middle age (41 to 65 years old),and old age (≥66 years old). All patients received gastroscopy, gastric mucosal biopsy, Hp culture and drug sensitivity test of clarithromycin and levofloxacin.
    ResultsThe Hp positive rate showed a significant downward trend in 2016, 2017 and 2018 (χ2=14.317, 47.079, 88.054,all P<0.05). The average resistance rate of Hpto clarithromycin from 2014 to 2018 was 22.72% (4 732/20 831) showing an increasing trend, but the increase was slower after 2017. The average resistance rate to levofloxacin was 30.55% (6 364/20 831), and the overall trend showed a sharp rise from 2015 to 2017 (χ2=38.383, 49.569, both P<0.05), and a significant decline was detected after 2017 (χ2=18.841, P<0.05). The resistance rate of Hp to levofloxacin in patients increased with age. The clarithromycin resistance rate first decreased and then increased with age, and the resistance rate in old age (32.52%, 763/2 346) was higher than that in youth (22.09%, 1 086/4 916) and middle age patients (21.21%, 2 854/13 458), and the differences were significant (χ2=991.071, 144.968, both P<0.05). The resistance rate of Hp rose from 12.73% (14/110) in juvenile to 43.31% (1 016/2 346) in old age (χ2=228.867, P<0.05).
    ConclusionIn recent years, the positive rate of Hpinfection in Wenling area has a decreasing trend. Although the resistance rate of Hp to clarithromycin and levofloxacin has been rising slowly or decreasing, it is still at a high level. In the selection of Hp eradication program, the differences between patients in different age groups should be considered with particular attention on the minors.

     

/

返回文章
返回